Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-08 8:12 pm Sale | 2025-12-04 | 13G | Ocular Therapeutix, Inc. OCUL | SUMMER ROAD LLC | 12,134,357 5.700% | -2,226,276 (-15.50%) | Filing History |
| 2025-11-14 5:34 pm Sale | 2025-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III, L.P. | 12,913,420 7.300% | -846,780 (-6.15%) | Filing History |
| 2025-11-14 08:20 am Sale | 2025-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital, LP | 13,095,855 6.180% | -2,362,283 (-15.28%) | Filing History |
| 2025-11-05 11:40 am Purchase | 2025-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | FMR LLC | 31,785,634 15.000% | 12,177,463 (+62.10%) | Filing History |
| 2025-10-17 6:24 pm Sale | 2025-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 10,170,232 5.800% | -1,183,932 (-10.43%) | Filing History |
| 2025-07-08 09:07 am Purchase | 2025-06-30 | 13G | Ocular Therapeutix, Inc. OCUL | FMR LLC | 19,608,171 12.300% | 17,574,572 (+864.21%) | Filing History |
| 2025-05-15 08:45 am Purchase | 2025-03-31 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital, LP | 15,458,138 9.650% | 6,227,369 (+67.46%) | Filing History |
| 2025-02-14 06:46 am Sale | 2024-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 4,342,500 2.760% | -1,727,500 (-28.46%) | Filing History |
| 2024-11-14 5:49 pm Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III, L.P. | 13,760,200 8.700% | 5,984,440 (+76.96%) | Filing History |
| 2024-11-14 09:37 am Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Avoro Capital Advisors LLC | 12,714,874 7.900% | 12,714,874 (New Position) | Filing History |
| 2024-11-12 4:49 pm Unchanged | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | The Vanguard Group | 8,384,183 5.370% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 11,354,164 7.300% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:42 pm Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | The Vanguard Group | 8,384,183 5.370% | 3,266,081 (+63.81%) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 11,354,164 7.300% | 5,592,631 (+97.07%) | Filing History |
| 2024-02-27 4:30 pm Purchase | 2024-02-26 | 13D | Ocular Therapeutix, Inc. OCUL | SUMMER ROAD LLC | 14,360,633 9.400% | 930,851 (+6.93%) | Filing History |
| 2024-02-14 7:48 pm Sale | 2023-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | Opaleye Management Inc. | 6,070,000 5.510% | -5,000 (-0.08%) | Filing History |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Ocular Therapeutix, Inc. OCUL | The Vanguard Group | 5,118,102 4.460% | 1,141,249 (+28.70%) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | BlackRock Inc. BLK | 5,761,533 5.200% | 808,796 (+16.33%) | Filing History |
| 2023-12-28 4:17 pm Purchase | 2023-12-18 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III, L.P. | 7,775,760 6.800% | 7,775,760 (New Position) | Filing History |
| 2023-12-22 4:04 pm Purchase | 2023-12-14 | 13G | Ocular Therapeutix, Inc. OCUL | Deep Track Capital, LP | 9,230,769 8.380% | 9,230,769 (New Position) | Filing History |